| |
Whole cohort (n = 273)
|
DAS28 remission (n = 102)
|
Only DAS28 remission (n = 75)
|
DAS28 + Boolean remission (n = 27)
|
Not in any remission (n = 171)
|
|---|
|
Age (years)
|
59.89 (7 to 85)
|
57.12 (7 to 85)
|
59.17 (26 to 85)
|
51.43 (7 to 75)
|
61.53 (30 to 86)
|
|
Disease duration (years)
|
13.43 (1 to 52)
|
11.1 (1 to 40)
|
12,23 (1 to 40)
|
7.91 (1 to 21)
|
14.68 (1 to 52)
|
|
Female (%)
|
74.7
|
68.6
|
66.7
|
74.1
|
78.4
|
|
RF positivity (%)
|
70.2
|
69.7
|
71.2
|
65.4
|
70.5
|
|
Anti-CCP positivity (%)
|
75.2
|
69.4
|
65.7
|
78.6
|
79.7
|
|
DAS28(4v)-CRP
|
5.33 ± 1.07
|
5.15 ± 1.1
|
5.18 ± 1.16
|
5.08 ± 0.9
|
5.44 ± 1.05
|
|
TJC28
|
10.24 ± 6.86
|
8.71 ± 6.83
|
9.19 ± 7.34
|
7.37 ± 5.05
|
11.15 ± 6.73
|
|
SJC28
|
9.86 ± 6.20
|
9.6 ± 6.25
|
9.73 ± 6.57
|
9.22 ± 5.36
|
10.02 ± 6.19
|
|
CRP (mg/dl)
|
2.76 ± 2.93
|
3.16 ± 3.14
|
3.23 ± 3.12
|
2.93 ± 3.26
|
2.53 ± 2.78
|
|
PGH
|
5.92 ± 2.28
|
5.6 ± 2.29
|
5.57 ± 2.33
|
5.68 ± 2.22
|
6.12 ± 2.26
|
- Data presented as mean (range), mean ± standard deviation or percentage. DAS28, disease activity score based on 28-joint count; RF, rheumatoid factor; anti-CCP, anti-cyclic-citrullinated peptide antibody; DAS28(4v)-CRP, disease activity score based on 28-joint count, C-reactive protein and patient global health; TJC28, tender joint count out of 28 joints; SJC28, swollen joint count out of 28 joints; CRP, C-reactive protein; PGH, patient global health.
